From Lab to Launch: A Step-by-Step Guide to Venture Building for Researchers

Recent Trends

A growing number of researchers are moving beyond traditional publication and grant cycles to form their own ventures. University technology transfer offices report increased inquiries about spinout formation, and several major research institutions have launched dedicated venture-building programs. These programs often provide structured pathways from discovery to company creation, blending academic rigor with startup methodologies.

• Specialized accelerators: Many universities now host accelerators designed exclusively for deep-tech and life-science teams, offering mentorship and seed funding in exchange for equity or milestones.
• Hybrid roles: The rise of “entrepreneur-in-residence” positions allows senior researchers to test commercial ideas while retaining academic affiliations.
• Multi-institutional consortia: Cross-institutional collaborations are forming to share resources for early-stage commercialisation, particularly in fields like advanced materials and synthetic biology.

Background

The classic model of research commercialisation involved licensing a patent to an existing company. That approach remains common, but researchers are increasingly opting to build startups themselves—a process often called venture building. This shift reflects broader changes in innovation policy, where governments and funding agencies now explicitly encourage entrepreneurship as a pathway to economic impact. However, the journey from lab bench to market remains complex, requiring skills far beyond the typical scientific training.

• IP management: Researchers must navigate ownership of intellectual property, which often rests with the host institution. Many universities have updated their policies to offer more favorable terms to founding teams, but negotiations can still be protracted.
• Funding gaps: Early-stage ventures face a “Valley of Death” between proof-of-concept grants and venture capital. Some researchers rely on non-dilutive awards, while others seek angel investors acquainted with deep tech.
• Team building: A lab-focused researcher may lack business, regulatory, or engineering expertise. Venture building often requires assembling a co-founding team that complements scientific strengths with commercial experience.

User Concerns

Researchers considering venture building raise several recurring issues. While each situation is unique, common themes emerge across disciplines and geographies.

1. Time commitment and academic pressure: Tenure-track faculty worry that entrepreneurship detracts from research and teaching obligations. Some institutions now allow “course relief” or temporary leave for spinout activities, but policies vary widely.
2. Conflict of interest: Running a startup while supervising graduate students or using university labs raises ethical and administrative questions. Clear separation of resources and personnel is often required.
3. Loss of control: Taking outside investment typically means ceding some decision-making power. Researchers accustomed to directing their own lab culture may find this transition difficult.
4. Market uncertainty: Even technically sound discoveries may lack a clear product-market fit. Validation through customer discovery interviews is a step many researchers initially skip, leading to misaligned product development.
5. Legal and regulatory hurdles: Fields like medical devices, diagnostics, and agricultural biotech face stringent approval processes. The time and cost required often surprise first-time founders.

Likely Impact

If current trends continue, venture building for researchers will likely accelerate the pipeline from discovery to deployment. This could shorten the typical lag between a published breakthrough and its first commercial use—often cited as five to fifteen years. However, the impact depends on how effectively institutions and policymakers address the structural barriers.

• More translational research: As venture-building programs mature, researchers may design experiments with commercial end-uses in mind from the outset, improving relevance without compromising fundamental science.
• New funding instruments: Several public and private organizations are testing “venture studios” that co-create startups with academics, sharing risk and providing operational support in exchange for a stake.
• Regional economic development: University spinouts tend to locate near their parent institutions, reinforcing local innovation ecosystems. This pattern could help distribute high-tech growth beyond traditional hubs like Boston and the Bay Area.
• Evolving career paths: The rise of venture building may create a new hybrid professional—the “scientist-entrepreneur”—who moves fluidly between lab and boardroom, influencing both research agendas and investment priorities.

What to Watch Next

Several developments will shape how thoroughly venture building becomes embedded in the research culture over the next few years.

Ultimately, the success of venture building for researchers will hinge on whether the support infrastructure can keep pace with enthusiasm. The next few years will likely see a growing number of “how-to” guides and structured programs, but the fundamental challenge remains the same: bridging the gap between discovery and demand without compromising the integrity of either.